Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma

Published:2014-03-07 Issue:11 Volume:55 Page:2490-2496
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Shin Ho-Jin¹,Lee Won-Sik²,Lee Ho-Seop³,Kim Hawk⁴,Lee Gyeong-Won⁵,Song Moo-Kon¹,Kim Jin Seok⁶,Yhim Ho-Young⁷,Chung Joo Seop¹

Affiliation:

1. Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea

2. Division of Hematology-Oncology, Busan Paik Hospital, Busan, Korea

3. Division of Hematology-Oncology, Kosin University Gospel Hospital, Busan, Korea

4. Division of Hematology-Oncology, Ulsan University Hospital, Ulsan, Korea

5. Division of Hematology-Oncology, Gyeongsang National University Hospital, Jinju, Korea

6. Division of Hematology-Oncology, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea

7. Division of Hematology-Oncology, Chonbuk National University Hospital, Jeonju, Korea

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.882504

Reference28 articles.

1. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

2. High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

3. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

4. Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

5. Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022

2. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022

3. Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement;The Journal of Medical Investigation;2021

4. Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL);Bone Marrow Transplantation;2020-04-17

5. Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma;Annals of Hematology;2020-02-05